Pathogenesis of Chronic Obstructive Pulmonary Disease: Understanding the Contributions of Gene-environment Interactions Across the Lifespan
Overview
Affiliations
The traditional view of chronic obstructive pulmonary disease (COPD) as a self-inflicted disease caused by tobacco smoking in genetically susceptible individuals has been challenged by recent research findings. COPD can instead be understood as the potential end result of the accumulation of gene-environment interactions encountered by an individual over the life course. Integration of a time axis in pathogenic models of COPD is necessary because the biological responses to and clinical consequences of different exposures might vary according to both the age of an individual at which a given gene-environment interaction occurs and the cumulative history of previous gene-environment interactions. Future research should aim to understand the effects of dynamic interactions between genes (G) and the environment (E) by integrating information from basic omics (eg, genomics, epigenomics, proteomics) and clinical omics (eg, phenomics, physiomics, radiomics) with exposures (the exposome) over time (T)-an approach that we refer to as GETomics. In the context of this approach, we argue that COPD should be viewed not as a single disease, but as a clinical syndrome characterised by a recognisable pattern of chronic symptoms and structural or functional impairments due to gene-environment interactions across the lifespan that influence normal lung development and ageing.
Ji J, Zhao Q, Yuan J, Yuan Z, Gao N Int J Chron Obstruct Pulmon Dis. 2025; 20:601-610.
PMID: 40078930 PMC: 11899904. DOI: 10.2147/COPD.S498513.
Jing X, Li Y Int J Chron Obstruct Pulmon Dis. 2025; 20:581-600.
PMID: 40078927 PMC: 11899922. DOI: 10.2147/COPD.S493749.
Gong G, Shen S, Shen S, Wang R, Zheng T, Xu W Respir Res. 2025; 26(1):98.
PMID: 40075503 PMC: 11905641. DOI: 10.1186/s12931-025-03170-4.
Investigating the role of eight SNPs in for COPD susceptibility in the Chinese elderly population.
Zheng Y, Zhao J, Liu M, Liu Y, Ding Y, Xie T Ann Med. 2025; 57(1):2474726.
PMID: 40072291 PMC: 11905312. DOI: 10.1080/07853890.2025.2474726.
Influence and role of polygenic risk score in the development of 32 complex diseases.
Liu Y, Hou W, Gao T, Yan Y, Wang T, Zheng C J Glob Health. 2025; 15:04071.
PMID: 40063714 PMC: 11893022. DOI: 10.7189/jogh.15.04071.